Table 1 Clinical characteristics of the Subjects.

From: Assessment of Lower-limb Vascular Endothelial Function Based on Enclosed Zone Flow-mediated Dilation

Variables

Total (n = 327)

Age, y

55.9 ± 21.2

Body mass index, kg/m2

24.0 ± 11.5

Systolic blood pressure, mmHg

133.3 ± 23.2

Diastolic blood pressure, mmHg

62.0 ± 11.0

Heart rate, bpm

66.9 ± 11.9

Ankle brachial pressure index

1.10 ± 0.14

Total cholesterol, mmol/L

182.3 ± 37.8

Triglycerides, mmol/L

121.2 ± 72.8

HDL-C, mmol/L

57.4 ± 16.1

LDL-C, mmol/L

106.6 ± 32.9

Glucose. mmol/L

110.6 ± 43.4

Hypertension, n, %

173 (58.1%)

Dyslipidemia, n, %

158 (53.0%)

Diabetes mellitus, n, %

73 (24.5%)

Smoking, n, %

39 (13.2%)

Coronary heart disease, n, %

63 (21.1%)

Cerebrovascular disease, n, %

26 (8.7%)

Peripheral artery disease, n, %

25 (8.4%)

Framingham risk score, %

15.1 ± 10.8

ezFMD, %

23.0 ± 14.5

  1. All results are presented as mean ± S.D. or number (%).
  2. HDL-C, high-density lipoprotein cholesterol;
  3. LDL-C, low-density lipoprotein cholesterol;
  4. ezFMD, enclosed zone flow-mediated dilation.